Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | BI 1831169 |
Trade Name | |
Synonyms | BI1831169|BI-1831169 |
Drug Descriptions |
BI 1831169 is a vesicular stomatitis virus (VSV)-derived oncolytic chimeric virus containing a modified glycoprotein, which may lead to reduced neurotoxicity, increased tumor lysis, and immune cell-mediated tumor cell killing (PMID: 35699077, PMID: 24812275). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C186270 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
BI 1831169 | BI 1831169 | 0 | 1 |
BI 1831169 + Ezabenlimab | BI 1831169 Ezabenlimab | 0 | 1 |